The Marzetti Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MZTI research report →
Range $130 – $135
Price Chart
About the company
The Marzetti Company is a producer and distributor of various specialized food items. Their extensive product line includes garlic breads, dinner rolls, salad dressings, dips, pasta, and croutons. These offerings are supplied to both retail outlets for consumers and the commercial foodservice industry across the United States.
- CEO
- David A. Ciesinski
- IPO
- 1980
- Employees
- 3,500
- HQ
- Westerville, OH, US
AI snapshot
Six angles, distilled from the data.
The stock is in a long corrective regime, trading below its 200-day average of 123.20 after a sharp reset from the 52-week high of 171.90. The 50-day average near 104.62 sits close to the current base, suggesting stabilization, but the broader trend still needs a sustained reclaim of longer-term resistance.
Street sentiment is cautious, with a Hold consensus and a 132.5 average target that still sits above the market. Recent target cuts from Stephens and D.A. Davidson show expectations have been reset lower, but the target remains materially above the current level, leaving room if execution improves.
The earnings profile is uneven: 2 beats in the last 8 quarters, with the most recent quarter missing by 16.8%. Next-year EPS is still modeled higher at 7.22 versus 6.34 TTM, so shareholders should watch for margin discipline and whether revenue can reaccelerate after a 2.4% YoY decline.
Recent activity leans to net selling, but most of the tape is award, vesting, and tax-related noise rather than discretionary conviction. The only clear open-market sale was 997 shares by Luis Viso, while the larger cluster of A and F transactions points to routine equity compensation processing.
Profitability remains solid for a defensive food name, with gross margin at 24.5%, operating margin at 8.61%, and net margin at 9.06%. Free cash flow was $361.5 million in fiscal 2026, and the balance sheet is net cash by $105.9 million, giving the setup a sturdy financial floor despite recent EPS and revenue softness.
MZTI looks like a high-quality staples operator with stronger cash generation than many packaged-food peers, but growth has been softer, with revenue down 2.4% YoY. At 15.57x earnings, it trades at a moderate valuation for the sector rather than a deep discount or premium.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.05B
- P/E
- 17.21
- Fwd P/E
- 17.41
- PEG
- 5.58
- P/S
- 1.55
- P/B
- 2.83
- EV/EBITDA
- 10.64
- Div Yield
- 3.66%
- Gross Margin
- 24.47%
- Op Margin
- 11.46%
- Net Margin
- 9.06%
- ROE
- 16.83%
- ROIC
- 12.52%
Latest fiscal year · YoY change
- Revenue
- $1.93B+1.1%
- Gross Profit
- $477.29M+4.7%
- Op Income
- $238.71M
- Net Income
- $191.61M+14.5%
- EPS
- $6.98+14.8%
- OCF Growth
- +8.5%
- FCF Growth
- +1.3%
- 52W High
- $176.26
- 52W Low
- $97.00
- 50D MA
- $104.42
- 200D MA
- $122.33
- Beta
- 0.33
- RSI (14)
- 59
- Avg Volume
- 412.67K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Marzetti posted a weak first quarter as cyclospora and higher freight costs pressured sales, margins, and EPS, but management still sees mid-single-digit full-year growth supported by Bachan's, Chick-fil-A, and new product launches.· November 3, 2026
- Consolidated net sales fell 2.4% to $481.5 million, operating income dropped to $41.4 million, and diluted EPS declined to $1.07 from $1.71.
- Excluding TSA sales, adjusted net sales were down 0.3%; management said cyclospora reduced revenue by about 300 basis points.
- Gross profit decreased $8 million to $110.8 million and reported gross margin fell 110 basis points, with about a 120 basis point freight headwind.
- Retail sales rose 2.0% to $252.7 million, helped by $17.8 million of Bachan's sales and strong Texas Roadhouse rolls growth.
- Management reiterated full-year mid-single-digit net sales growth and now expects full-year gross margin expansion of 25 to 75 basis points, with Q2 margins expected to be flat year over year.
Reported first-quarter consolidated net sales declined 2.4% to $481.5 million. Operating income decreased $17.8 million to $41.4 million, gross profit fell $8 million to $110.8 million, reported gross margin declined 110 basis points, and diluted EPS was $1.07, down $0.64 or 37.4% from the prior year. Excluding noncore TSA sales, adjusted net sales declined 0.3%; management estimated cyclospora reduced revenue by about 300 basis points. Retail sales increased 2.0% to $252.7 million, while Foodservice sales excluding TSA fell 2.6%. For the full year, management still expects mid-single-digit net sales growth, expects Q2 gross margins to be flat, and now sees full-year gross margin expansion of 25 to 75 basis points. Capex remains forecast at $90 million, the tax rate for the remainder of fiscal 2027 is expected to be 23%, and the company ended the quarter with less than $200 million of debt and an effective interest rate of about 5%.
Dave Ciesinski framed the quarter as an unusual disruption rather than a structural break, pointing to cyclospora and freight inflation as the main hits. He said the outbreak was concentrated in the Great Lakes, where the company has outsized exposure, and noted that the impact has moderated in recent weeks. He sounded constructive on the rest of the year, highlighting the return of marketing spending, pricing actions, and a pipeline of new items across Retail and Foodservice.
Tom Pigott emphasized that first-quarter results were worse than expected because both cyclospora and fuel-related freight costs were heavier than planned. He quantified a roughly 120 basis point freight headwind and an additional 40 basis point hit from cyclospora-related mix and lost cost savings, then said Q2 margins should be flat before improvement returns in the second half. He also gave specific capital and balance-sheet details: operating cash flow was $51 million, capex was $17.8 million in the quarter with a full-year capex forecast of $90 million, the quarterly dividend was $1 per share, and debt was below $200 million.
Analysts focused on whether cyclospora could set up an outsized recovery, and management said the Great Lakes concentration could create a stronger rebound as the category normalizes and advertising returns in January. Questions also centered on freight and gross margin, with management saying the freight headwind continues through Q2 but should moderate later, supporting the updated 25 to 75 basis point full-year margin expansion view. On growth drivers, management said Chick-fil-A sauce should add to Foodservice in Q2 and Q3, Bachan's should remain a lower-double-digit growth brand this year, and newer initiatives like mayo, Tajin, and Marzetti-branded sauces are more likely to matter in fiscal 2028 than in fiscal 2027.
The company said the cyclospora impact has largely moderated, which could allow the business to recover from an unusually soft quarter. Bachan's continues to outperform with double-digit sales growth, rising distribution, and faster velocity gains, while Texas Roadhouse rolls and New York Bakery are also performing well. Management still believes it can deliver mid-single-digit full-year sales growth and modest margin expansion.
The quarter showed meaningful vulnerability to external shocks, with cyclospora, freight inflation, and production-related disruption driving a 37.4% EPS decline and a 110 basis point gross margin drop. Base business organic volume was still described as low single-digit down even after stripping out cyclospora, and management called dressings the softest category. Freight pressure is expected to continue into Q2, and several new initiatives are not expected to contribute materially until later fiscal periods.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 71.4%
- Shares Outstanding
- 27.24M
- Float Shares
- 19.46M
Buy/sell ratio 1.11. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 282 ETFs
Biggest fund positions in MZTI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 26, 26 | Christenson Mark E | other | 0 |
| Sep 10, 26 | Viso Luis | sell | 997 |
| Aug 25, 26 | Viso Luis | other | 527 |
| Aug 25, 26 | Viso Luis | other | 152 |
| Aug 25, 26 | Pigott, Thomas K. | other | 1,026 |
| Aug 25, 26 | Pigott, Thomas K. | other | 298 |
| Aug 25, 26 | Ciesinski David Alan | other | 4,177 |
| Aug 25, 26 | Ciesinski David Alan | other | 1,611 |
| Aug 25, 26 | Bird Kristin | other | 623 |
| Aug 25, 26 | Bird Kristin | other | 180 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MZTI coverage
Recent articles, reports, and earnings notes.

The Marzetti Company (MZTI): Hold for Cash Flow, Wait on Growth
The Marzetti Company combines strong cash generation and category-leading brands with sluggish sales and repeated earnings misses. The stock looks like a Hold as execution improves, but valuation still leaves limited room for error.

The Marzetti Company (MZTI) gains on deep earnings analysis
The Marzetti Company (MZTI) gained after a deeper look at fiscal Q4 results showed an EPS beat, record gross profit, and margin expansion despite softer revenue. This analysis goes beyond the headline to examine brand momentum, segment trends, guidance, and the key questions shaping the stock’s next move.

The Marzetti Company (MZTI) gains on earnings beats
The Marzetti Company (MZTI) gains 2.0% after reporting earnings beats, as investors react positively to the latest quarterly results and improved outlook.
Want a deeper read on MZTI?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Marzetti: Undervalued But Near-Term Inflation Pressures Keep It A Hold
seekingalpha.com · Nov 12
The Marzetti Company Increases Regular Cash Dividend; Elects Three Incumbent Directors
businesswire.com · Nov 11
Marzetti: Q1 Wasn't Great, But That Is Likely As Bad As It Gets
seekingalpha.com · Nov 10
3 Dividend Stocks to Buy in November and Hold Forever
fool.com · Nov 10
D.A. Davidson & CO. Makes New $945,000 Investment in The Marzetti Company $MZTI
defenseworld.net · Nov 6
The Marzetti Company (MZTI) Q1 2027 Earnings Call Transcript
seekingalpha.com · Nov 3
The Marzetti Company Reports First Quarter Sales and Earnings
businesswire.com · Nov 3
The Marzetti Company and Tajín Announce Plans to Bring Bold, Authentic Flavor to the Dressing Aisle
businesswire.com · Nov 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 7, 2026 · Live quote · Not investment advice